Chat with us, powered by LiveChat

Atrial Fibrillation Surgery Market (Product - Catheter Ablation Product, and Surgical Ablation Product; Procedures - Catheter Ablation Procedure, and Surgical Ablation Procedure; End-user - Hospitals, Clinics, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

Atrial Fibrillation Surgery Market (Product - Catheter Ablation Product, and Surgical Ablation Product; Procedures - Catheter Ablation Procedure, and Surgical Ablation Procedure; End-user - Hospitals, Clinics, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

Report Code: HC0397 Category: Healthcare & Medical Devices Published: December, 2020

A recent report published by Infinium Global Research on atrial fibrillation surgery market provides in-depth analysis of segments and sub-segments in the global as well as regional atrial fibrillation surgery market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional atrial fibrillation surgery market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of global atrial fibrillation surgery market. According to the report, the global atrial fibrillation surgery market is projected to grow at a CAGR of 13.7% over the forecast period of 2020-2026.

 

Market Insight

Surgical treatment is greatly effective in converting atrial fibrillation back to sinus rhythm and considerably prevents thromboembolism postoperatively. According to WHO, atrial fibrillation is the most common type of arrhythmia and 8% of people over the age of 80 suffer from some form of atrial fibrillation. The incidence of atrial fibrillation continues to increase worldwide as people live longer and industry responded to this problem with advanced technologies and a plethora of monitoring devices.

 

The factors such as the surging volume of patients suffering from heart-related disorders and increasing preferences towards catheter ablation for cardiac arrhythmia treatment enhance the growth of the atrial fibrillation market. During the coronavirus pandemic, atrial fibrillation turned out to be a common clinical manifestation in hospitalized patients with covid-19. Over the medium and short term, the market for atrial fibrillation surgery is expected to propel due to rising cases of atrial fibrillation in the aging population. Moreover, monitoring devices such as single lead ECG adhesives sensors, implantable loop recorders, smartphone attachments, and wearables are influencing the growth trajectory of the atrial fibrillation surgery market. However, a shortage of skilled and trained professionals is expected to hamper the atrial fibrillation market growth. The increasing advancement in technology along with growing applications from emerging countries will further bring various opportunities for the growth of the global atrial fibrillation market. Coronavirus disease outbreak is a public health emergency of international concerns because of a highly pathogenic human coronavirus. Coronavirus affects the respiratory system, primarily the lungs. But it could also affect the heart, especially a diseased heart that has previously been struggling to get oxygenated blood all over the body. Due to which the demand for atrial fibrillation has increased in pandemic duration.

 

Among the regions, North America is expected to hold the largest share in the global atrial fibrillation surgery market with the steady growth of stand-alone SA operations. Patient selection, improvement of surgical techniques, and long-term follow-ups are the factors impacting the market growth in this region.  Moreover, a favorable regulatory scenario is impacting the growth of the market in this region. The U.S. is the foremost revenue contributor in the North America region. According to American Heart Association (AHA), each year about 200,000 to 400,000 new atrial fibrillation cases found in the U.S. Further, the Asia Pacific region is expected to witness steady growth due to the prevalence of atrial fibrillation in this region. Also, adaptive and business-friendly regulatory policies in Asia Pacific countries are contributing to the growth of the market in this region.


Global Atrial Fibrillation Surgery Market

 

Segment Covered

The report on global atrial fibrillation surgery market covers segments such as product, procedures, and end-user. On the basis of product, the sub-markets include catheter ablation product, and surgical ablation product. On the basis of procedures, the sub-markets include catheter ablation procedure, and surgical ablation procedure. On the basis of end-user, the sub-markets include hospitals, clinics, and others.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Biosense Webster, Inc., Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Atricure, Inc., Cardiofocus, Inc., Ncontact, Inc., Carima, Inc., Biotroik Se & Co.kg, and Johnsons & Johnson Ltd.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of atrial fibrillation surgery market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.